세계의 관절 치환술 기기 시장 : 제품별, 수술별, 유형별, 수술법별, 최종사용자별 - 예측(-2030년)

The global joint replacement devices market is expected to reach 31.09 billion by 2030 from USD 23.42 billion in 2024, at a CAGR of 4.8% from 2024 to 2030. Technological advancements such as use of 3D printing with the manufacturing process, introduction of smart implants, and increased access to latest and innovative implants supports the growth of joint replacement devices market. Further, rising number of sport injuries and increased incidence of accidents that may result in fractures damage to the joints has resulted in rising demand for the joint replacement devices.

"The knee replacement devices segment of product segment held the largest share of the market in 2023"

The joint replacement devices market is segmented based on product into knee replacement devices, hip replacement devices, shoulder replacement devices, elbow replacement devices, ankle replacement devices, wrist replacement devices, other replacement devices, and bone graft substitutes. The knee replacement devices accounted for a the highest share in 2023. Launch of smart knee replacement devices, rise in number of obese population, and increasing awareness initiatives is anticipated to fuel the growth of the segment. Developments knee replacement procedures with an assistance of robotic platform improves patient outcome significtly and is one of the important factors propelling the segment. For instance, the Mako Total Knee Replacement from Stryker Corporation (US) may result in less discomfort and a reduced recovery period as compared to traditional surgery.

"The total replacement segment of surgery type segment held the largest share of the market in 2023"

The joint replacement devices market can be segmented based on surgery type into total replacement, partial replacement, and revision replacement. Growing number for joint replacement surgeries such as knee and hip replacement surgeries and the unique properties of newly launched implants such as longevity and resistance to corrosion drives the segment growth. Increasing funding opportunities and advancements in robotic surgery drives the segment growth. Furthermore, the new and innovative implants assist with reduction in pain, fewer follow ups, reduced revisions, etc. that ultimately supports the growth of the market.

"The ambulatory care centers and trauma units segment for the end user segment is projected to register a significant CAGR during the forecast period."

The joint replacement devices market is segmented by end-users into hospitals & surgical centers, ambulatory care centers & trauma units, and orthopedic clinics. The ambulatory care centers and trauma units are expected to witness a significant growth during the forecast period. According to Definitive Healthcare there has been a 304% rise in knee replacement surgical procedures performed in ambulatory surgery centers during the period of 2018-2022. Increased accessibility and cost effectiveness at ambulatory care centers anticipated to propel the segment growth. Furthermore, rising preference for minimally invasive surgical techniques is expected to support the growth of this segment.

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in joint replacement devices market. Increasing number of investments, improved healthcare infrastructure and increasing investments in the emerging countries, majorly supports the demand for joint replacement devices. Furthermore, market leaders taking remarkable efforts to strengthen their reach in the Asia Pacific market to meet the growing demand for joint replacement devices. According to International Osteoporosis Foundation, more than 50% of osteoporotic hip fractures are expected to occur by 2050.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
• By Designation: Director-level-10%, C-level-14%, and Others-76%
• By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and Middle East & Africa - 2%

The prominent players in the joint replacement devices market are as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany), Arthrex, Inc.(US), Enovis (US), Globus Medical, Inc. (US), Acumed LLC (US), Orthofix Medical Inc.(US) , MicroPort Scientiifc Corporation (China), CONMED Corporation (US), Medacta International (Switzerland), Paragon 28, Inc. (US) and, Meril Life Sciences Pvt. Ltd. (India).

The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments, and key market strategies.

Research Coverage

This report studies the joint replacement devices market based on product, surgery type, type, technique, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall joint replacement devices market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

• Analysis of key drivers (increasing demand for minimally invasive orthopaedic surgical procedures and rising number of sports injuries, increasing prevalence of orthopaedic diseases and disorders, and increasing research funding and initiatives adopted by orthopaedic manufacturers to promoted brand awareness, increasing adoption of sensor-based implants), restraints (risk and complications associated with orthopaedic surgical procedures, high costs associated with orthopaedic treatments, reduced reimbursements for orthopedic surgical procedures), opportunities (rising number of hospitals and shift towards outpatient care, advancement in robotic assisted orthopaedic surgeries and 3D printing), and challenges (dearth of skilled orthopaedic surgeons) influencing the growth of the joint replacement devices market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the joint replacement devices market
• Market Development: Comprehensive information about lucrative markets-the report analyses the joint replacement devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the joint replacement devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary research
    • 2.1.1.2 Key objectives of secondary research
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key primary insights
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
    • 2.2.1.2 Customer-based market estimation
    • 2.2.1.3 Growth forecast approach
    • 2.2.1.4 CAGR projections
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 STUDY ASSUMPTIONS
  • 2.5.1 PARAMETRIC ASSUMPTIONS
  • 2.5.2 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 JOINT REPLACEMENT DEVICES MARKET OVERVIEW
• 4.2 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
• 4.3 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2024 VS. 2030 (USD MILLION)
• 4.4 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
• 4.5 GEOGRAPHIC SNAPSHOT OF JOINT REPLACEMENT DEVICES MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of orthopedic diseases and disorders
    • 5.2.1.2 Increasing demand for minimally invasive surgery
    • 5.2.1.3 Rising adoption of sensor-based implants
    • 5.2.1.4 Rising number of sports injuries
    • 5.2.1.5 Increasing research funding
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Risks and complications associated with orthopedic surgical procedures
    • 5.2.2.2 Reduced reimbursement rates for orthopedic surgeries
    • 5.2.2.3 High cost of orthopedic surgery
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Advancements in robotic surgery and 3D printing
    • 5.2.3.2 Growth opportunities in emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Dearth of skilled orthopedic surgeons
• 5.3 VALUE CHAIN ANALYSIS
  • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
  • 5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
  • 5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
• 5.4 SUPPLY CHAIN ANALYSIS
  • 5.4.1 MANUFACTURERS
    • 5.4.1.1 Prominent companies
    • 5.4.1.2 Small and medium-sized enterprises
  • 5.4.2 END USERS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 REGULATORY ANALYSIS
  • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.6.2 REGULATORY FRAMEWORK
    • 5.6.2.1 North America
      • 5.6.2.1.1 US
      • 5.6.2.1.2 Canada
    • 5.6.2.2 Europe
    • 5.6.2.3 Asia Pacific
      • 5.6.2.3.1 Japan
      • 5.6.2.3.2 China
      • 5.6.2.3.3 India
    • 5.6.2.4 Latin America
      • 5.6.2.4.1 Brazil
  • 5.6.3 REGULATORY APPROVALS
• 5.7 REIMBURSEMENT SCENARIO
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
  • 5.9.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA
  • 5.10.2 EXPORT DATA
• 5.11 PATENT ANALYSIS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 CASE STUDY 1: DIGITAL PLATFORM DESIGNED TO IMPROVE PATIENT CARE PATHWAYS
  • 5.15.2 CASE STUDY 2: PARTIAL KNEE ARTHROPLASTY PERFORMED WITH ROSA PARTIAL KNEE SYSTEM
  • 5.15.3 CASE STUDY 3: ACCURATE DATA GENERATION WITH SHAPEGRABBER 3D
• 5.16 TECHNOLOGY ANALYSIS
  • 5.16.1 KEY TECHNOLOGIES
    • 5.16.1.1 3D printing/additive manufacturing
  • 5.16.2 COMPLEMENTARY TECHNOLOGIES
    • 5.16.2.1 Robotic orthopedic surgery
  • 5.16.3 ADJACENT TECHNOLOGIES
    • 5.16.3.1 Diagnostic imaging
• 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.18 UNMET NEEDS
• 5.19 IMPACT OF AI ON JOINT REPLACEMENT DEVICES MARKET
  • 5.19.1 KEY USE CASES

6 JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 KNEE REPLACEMENT DEVICES
  • 6.2.1 TOTAL KNEE REPLACEMENT DEVICES
    • 6.2.1.1 Ongoing innovation in knee implants to support market growth
  • 6.2.2 PARTIAL KNEE REPLACEMENT DEVICES
    • 6.2.2.1 Quick recovery and shorter hospital stays to drive segmental growth
  • 6.2.3 REVISION KNEE REPLACEMENT DEVICES
    • 6.2.3.1 Rising incidence of obesity and ongoing technological advancements to fuel growth
• 6.3 HIP REPLACEMENT DEVICES
  • 6.3.1 TOTAL HIP REPLACEMENT DEVICES
    • 6.3.1.1 Increasing number of hip fractures and increasing success rates of hip arthroplasty to support market
  • 6.3.2 PARTIAL HIP REPLACEMENT DEVICES
    • 6.3.2.1 Increasing geriatric population and rising focus on minimally invasive surgeries to boost market
  • 6.3.3 REVISION HIP REPLACEMENT DEVICES
    • 6.3.3.1 Improved longevity and better patient outcomes to drive growth
  • 6.3.4 HIP RESURFACING DEVICES
    • 6.3.4.1 Improved stability and faster recovery to boost segment
• 6.4 SHOULDER REPLACEMENT DEVICES MARKET
  • 6.4.1 TOTAL SHOULDER REPLACEMENT DEVICES
    • 6.4.1.1 Increasing launch of new shoulder replacement devices to support market growth
  • 6.4.2 PARTIAL SHOULDER REPLACEMENT DEVICES
    • 6.4.2.1 Growing incidence of rotator cuff disorders to drive growth
  • 6.4.3 REVERSE SHOULDER REPLACEMENT DEVICES
    • 6.4.3.1 Rising number of reverse shoulder arthroplasty procedures to boost market
• 6.5 ANKLE REPLACEMENT DEVICES
  • 6.5.1 TOTAL ANKLE REPLACEMENT DEVICES
    • 6.5.1.1 Growing number of ankle replacement procedures to fuel uptake
  • 6.5.2 ANKLE FUSION/FIXATION DEVICES
    • 6.5.2.1 Cost-effectiveness and improved surgical outcomes to propel market
• 6.6 ELBOW REPLACEMENT DEVICES
  • 6.6.1 INCREASING FREQUENCY OF ELBOW JOINT FRACTURES AND GROWTH IN ELDERLY POPULATION TO DRIVE MARKET
• 6.7 WRIST REPLACEMENT DEVICES
  • 6.7.1 GROWING NUMBER OF WRIST REPLACEMENT PROCEDURES TO DRIVE MARKET GROWTH
• 6.8 OTHER JOINT REPLACEMENT DEVICES
• 6.9 BONE GRAFT SUBSTITUTES
  • 6.9.1 COST-EFFECTIVE AND EASY AVAILABILITY OF BONE GRAFT SUBSTITUTES TO PROPEL MARKET

7 JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE

• 7.1 INTRODUCTION
• 7.2 TOTAL REPLACEMENT PROCEDURES
  • 7.2.1 INCREASING NUMBER OF HIP AND KNEE REPLACEMENT SURGERIES TO DRIVE MARKET GROWTH
• 7.3 PARTIAL REPLACEMENT PROCEDURES
  • 7.3.1 INCREASING INCIDENCE OF BONE-RELATED DISORDERS AND QUICKER RECOVERY PERIODS TO BOOST DEMAND
• 7.4 REVISION REPLACEMENT PROCEDURES
  • 7.4.1 DEVELOPMENT OF SPECIALIZED IMPLANTS TO FUEL DEMAND

8 JOINT REPLACEMENT DEVICES MARKET, BY TYPE

• 8.1 INTRODUCTION
• 8.2 CEMENTED FIXATION
  • 8.2.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES AND DECREASE IN REVISION PROCEDURES TO DRIVE MARKET
• 8.3 CEMENTLESS FIXATION
  • 8.3.1 IMPROVED STABILITY AND DURABILITY TO FUEL SEGMENT GROWTH
• 8.4 HYBRID FIXATION
  • 8.4.1 IMPROVED BONE GROWTH AND RAPID RECOVERY TO DRIVE MARKET
• 8.5 REVERSE HYBRID FIXATION
  • 8.5.1 RISING INCIDENCE OF OSTEOARTHRITIS AND INCREASING NUMBER OF HIP REPLACEMENT SURGERIES TO FUEL MARKET GROWTH

9 JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE

• 9.1 INTRODUCTION
• 9.2 TRADITIONAL SURGERY
  • 9.2.1 COST-EFFECTIVENESS AND HIGHER FAMILIARITY TO PROPEL MARKET GROWTH
• 9.3 MINIMALLY INVASIVE SURGERY
  • 9.3.1 REDUCED PAIN AND FASTER RECOVERY TO DRIVE DEMAND
• 9.4 COMPUTER-ASSISTED SURGERY
  • 9.4.1 IMPROVED ACCURACY AND REAL-TIME GUIDANCE TO FUEL GROWTH

10 JOINT REPLACEMENT DEVICES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS & SURGICAL CENTERS
  • 10.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES TO DRIVE MARKET
• 10.3 AMBULATORY CARE CENTERS & TRAUMA UNITS
  • 10.3.1 COST-EFFECTIVE TREATMENTS OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH
• 10.4 ORTHOPEDIC CLINICS
  • 10.4.1 RISING NUMBER OF ORTHOPEDIC CLINICS TO SUPPORT MARKET GROWTH

11 JOINT REPLACEMENT DEVICES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Growing focus on launching technologically advanced hybrid implants to drive market
  • 11.2.3 CANADA
    • 11.2.3.1 Rising incidence of degenerative bone diseases to support market growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Increasing focus on commercialization of joint replacement devices to boost demand
  • 11.3.3 FRANCE
    • 11.3.3.1 Increasing cases of obesity and subsequent rise in osteoporosis to drive market
  • 11.3.4 UK
    • 11.3.4.1 Increasing awareness of orthopedic conditions to boost demand
  • 11.3.5 ITALY
    • 11.3.5.1 Growing focus on preventive care for musculoskeletal injuries to drive market
  • 11.3.6 SPAIN
    • 11.3.6.1 Rising preference for MIS techniques to support market growth
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Rapidly growing geriatric population to propel market
  • 11.4.3 CHINA
    • 11.4.3.1 Expanding target patient population to drive market
  • 11.4.4 INDIA
    • 11.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 Favorable government initiatives for bone health awareness to fuel market
  • 11.4.6 SOUTH KOREA
    • 11.4.6.1 Favorable government support for healthcare access to support market growth
  • 11.4.7 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Expansion of global market players for advanced product commercialization to boost demand
  • 11.5.3 MEXICO
    • 11.5.3.1 Favorable investments for medical device manufacturers to support market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Rising focus on in-house manufacturing of advanced orthopedic devices to support market growth
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND/PRODUCT COMPARISON
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Region footprint
    • 12.7.5.3 Type footprint
    • 12.7.5.4 Surgery type footprint
    • 12.7.5.5 Type footprint
    • 12.7.5.6 Technique footprint
    • 12.7.5.7 End-user footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 ZIMMER BIOMET
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches and approvals
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 STRYKER
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches and approvals
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 JOHNSON & JOHNSON MEDTECH
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches and approvals
      • 13.1.3.3.2 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 SMITH+NEPHEW
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches and approvals
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 B. BRAUN
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 MnM view
      • 13.1.5.3.1 Right to win
      • 13.1.5.3.2 Strategic choices
      • 13.1.5.3.3 Weaknesses and competitive threats
  • 13.1.6 GLOBUS MEDICAL
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches and approvals
      • 13.1.6.3.2 Deals
  • 13.1.7 ARTHREX, INC.
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
  • 13.1.8 ENOVIS
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches and approvals
      • 13.1.8.3.2 Deals
      • 13.1.8.3.3 Expansions
  • 13.1.9 ACUMED LLC
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches and approvals
      • 13.1.9.3.2 Deals
      • 13.1.9.3.3 Expansions
  • 13.1.10 ORTHOFIX MEDICAL INC.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches and approvals
      • 13.1.10.3.2 Deals
  • 13.1.11 MICROPORT SCIENTIFIC CORPORATION
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product launches and approvals
      • 13.1.11.3.2 Deals
  • 13.1.12 CONMED CORPORATION
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Deals
  • 13.1.13 MEDACTA INTERNATIONAL
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Product launches and approvals
      • 13.1.13.3.2 Deals
      • 13.1.13.3.3 Expansions
  • 13.1.14 PARAGON 28, INC.
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Product launches and approvals
      • 13.1.14.3.2 Deals
  • 13.1.15 MERIL LIFE SCIENCES PVT. LTD.
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Expansions
  • 13.1.16 GPC MEDICAL LTD.
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products offered
  • 13.1.17 MAXX ORTHOPEDICS, INC.
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products offered
    • 13.1.17.3 Recent developments
      • 13.1.17.3.1 Product launches and approvals
      • 13.1.17.3.2 Deals
  • 13.1.18 AUXEIN
    • 13.1.18.1 Business overview
    • 13.1.18.2 Products offered
    • 13.1.18.3 Recent developments
      • 13.1.18.3.1 Deals
  • 13.1.19 NORAKER
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products offered
    • 13.1.19.3 Recent developments
      • 13.1.19.3.1 Product launches and approvals
      • 13.1.19.3.2 Deals
  • 13.1.20 NEXTSTEP ARTHROPEDIX
    • 13.1.20.1 Business overview
    • 13.1.20.2 Products offered
  • 13.1.21 EXACTECH, INC.
    • 13.1.21.1 Business overview
    • 13.1.21.2 Products offered
    • 13.1.21.3 Recent developments
      • 13.1.21.3.1 Product launches and approvals
      • 13.1.21.3.2 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 FH ORTHO
  • 13.2.2 SYMBIOS ORTHOPEDIE S.A.
  • 13.2.3 MADISON ORTHO
  • 13.2.4 GREEN SURGICALS PVT. LTD.
  • 13.2.5 SIORA SURGICAL PVT. LTD.
  • 13.2.6 ORTHOPEDIATRICS CORP.
  • 13.2.7 RESTOR3D
  • 13.2.8 DOUBLE MEDICAL TECHNOLOGY INC.
  • 13.2.9 TREACE MEDICAL CONCEPTS, INC.
  • 13.2.10 AK MEDICAL

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS